October 2008 Volume 4 Number 10
Visit Nature Clinical Practice Neurology online to browse the journal.
Now available at http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0ox40E4
=====================================================================
NeuroPod
The Neuroscience Podcast from Nature
Each month, join us as we delve into the latest research on the brain,
from its molecular makings to the mysteries of the mind. NeuroPod
brings you the best from Nature's neuroscience journals, conference
round-ups and special reports on the hottest areas in the field.
Listen to the podcast at:
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6sy0EI
Produced with support from The Dana Foundation
=====================================================================
----------------------
EDITORIAL
----------------------
Approaching a renaissance in coma research responsibly
Paul M Matthews
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6sz0EJ
----------------------
RESEARCH HIGHLIGHTS
----------------------
MRZ reaction could distinguish patients with NMO from those with MS
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6s10E5
Vitamin D supplements could guard against stroke
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6s20E6
Antisense RNA upregulates [beta]-secretase 1 in Alzheimer disease
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6s30E7
Metabolic syndrome predicts resistance to thrombolysis in stroke patients
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6s40E8
Disrupted calcium homeostasis implicated in Alzheimer disease pathogenesis
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6s50EA
Potential therapeutic role of microRNAs in glioblastoma multiforme
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6s60EB
Does plaque clearance halt progression of Alzheimer disease?
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6s70EC
In briefs
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6s80ED
----------------------
PRACTICE POINTS
----------------------
Neuroleptic discontinuation during dementia care: a recent trial and
its implications for practice
Chiadi U Onyike
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6tA0EN
Pushing or pulling to predict falls in Parkinson disease?
Christopher J Hass, Bastiaan R Bloem and Michael S Okun
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6tB0EO
Optic neuritis and the risk of multiple sclerosis-what can we learn from
a brain MRI scan?
Steven E Feldon
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6tC0EP
Kleine-Levin syndrome: a disease in its own right?
Jacob Taylor, Crystal Watkins and Adam Kaplin
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6tD0EQ
Transcranial ultrasound in the diagnosis of Parkinson's disease
WR Wayne Martin
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6tE0ER
The hyperdense internal carotid artery sign: a specific but limited
marker of occlusion in stroke
Michael D Hill
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6tF0ES
Eye signs in patients with parkinsonism: do they predict the development
of multiple system atrophy?
William A Fletcher
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6tG0ET
----------------------
VIEWPOINTS
----------------------
Neuroimaging, impaired states of consciousness, and public outreach
Judy Illes, Patricia W Lau and Joseph T Giacino
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6tH0EU
The changing spectrum of coma
Steven Laureys and Melanie Boly
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6tI0EV
----------------------
REVIEWS
----------------------
Neurological manifestations of Waldenstrom macroglobulinemia
Joachim M Baehring, Ephraim P Hochberg, Noopur Raje, Matthew Ulrickson
and Fred H Hochberg
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6tJ0EW
B cells as therapeutic targets in autoimmune neurological disorders
Marinos C Dalakas
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6tK0EX
McArdle disease: what do neurologists need to know?
Alejandro Lucia, Gisela Nogales-Gadea, Margarita Perez, Miguel A Martin,
Antoni L Andreu and Joaquin Arenas
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B6tL0EY
=====================================================================
FACT or FICTION?
Studies have reported that up to 60% of individuals with schizophrenia
and 68% of those with bipolar disorder are overweight/obese.
Do you know all the facts about obesity? Visit
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0B1Dm0EE
to test your knowledge.
=====================================================================
You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/ensh0Xztnp0HjL0Zzu0Ep
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact our customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
=====================================================================
